Nasdaq delisting determination
Company: Core Scientific
The claim, verbatim
December 22, 2022: Nasdaq determined common stock would be delisted due to Chapter 11 filing and concerns about ability to sustain compliance with listing requirements
Source (primary)
Core Scientific 10-K filed 2023-04-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “On December 22, 2022, the Company received written notice (the "Delisting Notice") from Nasdaq notifying the Company that, as a result of the Chapter 11 Cases, and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company's common stock would be delisted from Nasdaq”
How we checked this
Checked on September 21, 2026. The cited source supports every part of this claim.
The document confirms the December 22, 2022 delisting determination, its connection to the Chapter 11 Cases, and Nasdaq's stated compliance concerns.
Confirmed in the source:
- On December 22, 2022 Nasdaq determined the common stock would be delisted
- The delisting was tied to the Chapter 11 filing and concerns about sustaining compliance with listing requirements
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828023010454/core-20221231.htm) in full (860,799 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 10-K filed 2023-04-04
Quote: “On December 22, 2022, the Company received written notice (the "Delisting Notice") from Nasdaq notifying the Company that, as a result of the Chapter 11 Cases, and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company's common stock would be delisted from Nasdaq”